Empowered Funds, LLC Vanda Pharmaceuticals Inc. Transaction History

Empowered Funds, LLC

  • $6.59 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$4.61 - $6.34 $53,125 - $73,062
11,524 Added 5.32%
228,287 $1.07 Million
Q2 2024

Jul 30, 2024
BUY
$3.91 - $6.5 $60,526 - $100,620
15,480 Added 7.69%
216,763 $1.22 Million
Q1 2024

May 06, 2024
BUY
$3.47 - $4.61 $111,053 - $147,538
32,004 Added 18.91%
201,283 $827,000
Q3 2023

Nov 01, 2023
BUY
$4.28 - $6.57 $59,509 - $91,349
13,904 Added 8.95%
169,279 $731,000
Q2 2023

Jul 27, 2023
BUY
$5.9 - $6.95 $916,712 - $1.08 Million
155,375 New
155,375 $1.02 Million

Others Institutions Holding VNDA

# of Institutions
160
Shares Held
45M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $251M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email